Nanobiotix (NBTX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
1,696,126,000
EV to revenue ratio (TTM)
53.38
EV to ebitda
-2.447
Financial Performance
Revenue (TTM)
32,593,000
Gross profit (TTM)
32,593,000
EBITDA
-10,489,000
Profitability
Operating margin (TTM)
-196.40%
Profit margin
-73.50%
Return on assets (TTM)
-10.10%
Return on equity (TTM)
-198.70%
Per Share Metrics
Revenue per share (TTM)
0.68
EPS
-0.58
Diluted EPS (TTM)
-0.58
Book value
-1.99
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
42.37
PEG ratio
Price to sales ratio (TTM)
52.04
Price to book ratio (TTM)
65.02
Growth
Quarterly earnings growth (YoY)
186.80%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
0
Buy
4
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.566